Drug recall · July 24, 2019
Milrinone Lactate Injection 200 mcg recall
Why: Lack of Assurance of Sterility: Bags have the potential to leak.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Milrinone Lactate Injection 200 mcg (0.2 mg)/mL* in 5% Dextrose Injection 40 mg/200 mL, 200 mL bag, Rx Only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-2776-02, Barcode (01)00304092776028.
- Lots / codes
Lot #s: 86-615-KL, Exp. 1FEB2020; 87-701-KL, Exp. 1MAR2020; 90-114-KL, Exp. 1JUN2020
- Quantity
- 58200 bags
- Company
- Pfizer Inc., New York, NY
- Distribution
- United States, PR, and Guam
- Initiated
- July 9, 2019 · Voluntary: Firm initiated
- Classified
- July 12, 2019
- Reported
- July 24, 2019
- Ended
- October 27, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lactate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.